177 related articles for article (PubMed ID: 2465686)
1. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
2. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
4. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
5. [Effect of intravenous and intraductal glucocorticosteroids in experimental acute pancreatitis in dogs].
Kerekes L; Sipka S; Dezsö B; Furka A; Petö K; Bráth E; Mikó I; Furka I
Magy Seb; 2002 Aug; 55(4):225-8. PubMed ID: 12236076
[TBL] [Abstract][Full Text] [Related]
6. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
7. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats.
Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M
Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064
[TBL] [Abstract][Full Text] [Related]
8. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
9. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
[TBL] [Abstract][Full Text] [Related]
10. [Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)].
Büchler M; Malfertheiner P; Uhl W; Wolf HR; Schwab G; Beger HG
Med Klin (Munich); 1988 Apr; 83(10):320-4, 352. PubMed ID: 3135470
[No Abstract] [Full Text] [Related]
11. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
[TBL] [Abstract][Full Text] [Related]
12. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Gao HJ; Song Q; Lv FQ; Wang S; Wang YR; Luo YK; Mei XG; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):707-711. PubMed ID: 26489626
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
14. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
15. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
[TBL] [Abstract][Full Text] [Related]
16. The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats.
Chen HM; Hwang TL; Chen MF
J Surg Res; 1996 Dec; 66(2):147-53. PubMed ID: 9024827
[TBL] [Abstract][Full Text] [Related]
17. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
[TBL] [Abstract][Full Text] [Related]
19. Effects of delayed administration of octreotide in acute experimental pancreatitis.
Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y
J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496
[TBL] [Abstract][Full Text] [Related]
20. Early graft injuries after pancreatic transplantation in syngeneic rats. Cytoprotective effects of gabexate-mesilate.
Bassi C; Benetti L; Girelli R; Falconi M; Nifosí F; Coviello G; Cavallini G; Vesentini S; Dragonetti C; Pederzoli P
Int J Pancreatol; 1991 May; 8(4):345-53. PubMed ID: 1791320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
